Challenges in Viral Hepatitis and Liver Disease

13th Challenges in Viral Hepatitis and Liver Disease

Lausanne, 13 janvier 2022
Programme | rejoindre/join 

Prof. Alberto Sanchez-Fueyo
Cell-based and immune therapies in liver diseases

Ms. Carina Bobzin
Liver disease in 2022: the patient perspective

Prof. Robert Thimme
New insights into the immunopathogenesis and management
of hepatitis B

Dr. Patrizia Künzler-Heule
Liver disease in 2022: the specialized hepatology nurse perspective

Prof. Michelle Lai
Nonalcoholic steatohepatitis: Challenges and Opportunities

PD Dr. Thomas Greuter
Clinical Pearl

Lausanne, 16 janvier 2020
Programme

Prof. Thomas Berg
Viral hepatitis in immuno-compromised patients

Dr. Eleni Moschouri
Clinical pearl

Dr Montserrat Fraga
Diagnosis and management of immune checkpoint inhibitor-induced liver injury

Dr Florent Artru
Clinical pearl

Prof. Francesco Negro
Eliminating viral hepatitis by 2030

Lausanne, 10 janvier 2019
Programme

Prof. Jan Felix Drexler
Evolutionary biology of hepatitis viruses

Prof. Fabien Zoulim
HBV cure - where do we stand in 2019

Dr Maxime Robert
Clinical pearl

Dr Montserrat Fraga, PD Dr Emmanuel Melloul, Prof. Alban Denys and Dr Michel Montemurro
Advances and current challenges in hepatocellular carcinoma

Prof. Christian Toso
Current trends in liver transplantation
 

Lausanne, 26 janvier 2017
Programme​​​​​​​

Prof Henry L.Y. Chan
Addressing the challenges of hepatitis B in Asia

Dr Sébastien Godat
The tough viral hepatitis case 1

Prof Jean-Michel Pawlotsky
Management of heptatitis C in 2017

PD Dr Matthias Cavassini
The tough viral hepatitis case 2

Prof Francesco Negro
Hepatitis C in Switzerland: current challenges and perspectives

Lausanne, 28 janvier 2016
Programme​​​​​​​

Prof. Fabien Zoulim
Hepatitis B : current challenges and perspectives for cure.

Dre Astrid Marot
The tough hepatitis C case 1.

Prof Markus Cornberg
The challenge of hepatitis D in 2016.

Drs Karim Abdelrahman et Julien Vionnet
The tough hepatitis C case 2.

Prof Markus H. Heim
Hepatocellular carcinoma: the new frontier.

Lausanne, 22 janvier 2015
Programme​​​​​​​

Prof. Geoffrey M. Dusheiko
Treatment of chronic hepatitis C in 2015. Whom? When? How?

Dr Roxane Hessler and PD Dr Pierre Deltenre
Interactive clinical case presentation

Dr Harry R. Dalton
The emerging challenge of hepatitis E.

Dr Konstantin Burgmann and PD Dr Pierre Deltenre
Interactive clinical case presentation

Hepatitis E: The Lausanne experience.
Dr Jérôme Gouttenoire / Molecular virology
Dr Katharine E. Darling / Seroprevalnce studies
Dr Roland Sahli / Molecular testing
Dr Christopher Doerig / Acute and chronic hepatitis E in Switzerland

Lausanne, 16 Janvier 2014

Prof. Charles M. Rice
The HCV life cycle: achievements and challenges

Dr. Montserrat Fraga
Interactive clinical case presentation

Prof. Jean-Michel Pawlotsky
Treatment of hepatitis C in 2014 and beyond

Dr. Julien Vionnet
Interactive clinical case presentation

Prof. Beat Mülhaupt
Management of hepatitis C in special patient groups

Lausanne, 10 Janvier 2013

Prof F. Negro
Hepatitis B Virus, A Global Perspective

Prof S. Urban,
The Hepatitis B Virus Life Circle: Achievements and Challenges

Prof D. Moradpour
Management of HBV Infection: Current Status and Challenges